Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Nov 15, 2018; 10(11): 410-420
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410
Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410
Figure 1 Disease free survival by primary tumor localization in Kaplan-Meier analysis.
A: Stage II patients not receiving adjuvant therapy; B: Stage II patients receiving adjuvant therapy; C: Stage III patients not receiving adjuvant therapy; D: Stage III patients receiving adjuvant therapy; E: Stage III patients receiving adjuvant 5-fluorouracil based therapy; F: Stage III patients receiving adjuvant oxaliplatin based therapy. 5-FU: 5-Fluorouracil; DFS: Disease free survival; LCC: Left colon cancer; n: Number of patients; RCC: Right colon cancer.
- Citation: Sakin A, Arici S, Secmeler S, Can O, Geredeli C, Yasar N, Demir C, Demir OG, Cihan S. Prognostic significance of primary tumor localization in stage II and III colon cancer. World J Gastrointest Oncol 2018; 10(11): 410-420
- URL: https://www.wjgnet.com/1948-5204/full/v10/i11/410.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i11.410